Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Zentalis Pharmaceuticals Inc (NQ: ZNTL )

12.72 -0.24 (-1.81%)
Streaming Delayed Price Updated: 10:06 AM EST, Dec 11, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 211,460
Open 13.02
Bid (Size) 12.71 (7)
Ask (Size) 12.74 (1)
Prev. Close 12.96
Today's Range 12.65 - 13.40
52wk Range 9.560 - 31.46
Shares Outstanding 45,052,904
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Analyst Expectations for Zentalis Pharma's Future
Via Benzinga
Morgan Stanley Maintains Overweight Rating for Zentalis Pharma: Here's What You Need To Know
Via Benzinga

Performance

YTD
-38.38%
-38.38%
1 Month
+29.32%
+29.32%
3 Month
-49.00%
-49.00%
6 Month
-47.26%
-47.26%
1 Year
-36.41%
-36.41%

More News

Read More
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
TreeHouse Foods, EchoStar, Hilton Grand Vacations, EchoStar And Other Big Stocks Moving Lower On Monday
Via Benzinga
Topics Stocks
Exposures US Equities
Where Zentalis Pharma Stands With Analysts
Via Benzinga
Analyst Expectations for Zentalis Pharma's Future
Via Benzinga
Zentalis Gears Up for Phase 3 Study of Azenosertib after Positive Phase 1b Outcomes
Via Benzinga
Where Zentalis Pharma Stands With Analysts
Via Benzinga
Around $108M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
Via Benzinga
5 Short Squeeze Stocks In Play Thursday: Nikola, Verve, Carvana, More
Via Benzinga
Domino's Pizza, Patterson-UTI Energy, JinkoSolar And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Why Shares of Zentalis Pharmaceuticals Dropped This Week
Via The Motley Fool
Zentalis Pharma: Q1 Earnings Insights
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Newman Ferrara LLP Announces Corporate Governance Investigations of Zentalis Pharmaceuticals, Inc. (ZNTL)
From Newman Ferrara LLP
Via Business Wire
4 Analysts Have This to Say About Zentalis Pharmaceuticals
Via Benzinga
Oppenheimer Maintains Outperform Rating for Zentalis Pharmaceuticals: Here's What You Need To Know
Via Benzinga
Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday
Via Benzinga
Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday
Via Benzinga
This Analyst Says Zentalis' Increased Focus On WEE1 Program Is 'Prudent', Slashes Price Target By 37%
Via Benzinga
Why Amazon, Microsoft, Apple Shares Are Trading Lower, Here Are 50 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Citigroup Slashes Price Target On This Stock By 83%; Also Check Out Some Other Big PT Changes
Via Benzinga
Zentalis Pharmaceuticals: Q2 Earnings Insights
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 12, 2022
Via Benzinga
Advanced Clinical Trials Focus on Development of Vaccines to Prevent Ovarian Cancer Progression
Via FinancialNewsMedia
Topics Death
Exposures Death
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.